Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 74 of 392 for:    LENALIDOMIDE AND Dexamethasone

Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04009109
Recruitment Status : Not yet recruiting
First Posted : July 5, 2019
Last Update Posted : May 12, 2020
Sponsor:
Collaborators:
Janssen Scientific Affairs, LLC
Celgene Corporation
Takeda
Information provided by (Responsible Party):
Alliance Foundation Trials, LLC.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : July 1, 2025
Estimated Study Completion Date : July 31, 2025
Publications: